H. Eibl

2.9k total citations
66 papers, 2.4k citations indexed

About

H. Eibl is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, H. Eibl has authored 66 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Organic Chemistry and 10 papers in Biochemistry. Recurrent topics in H. Eibl's work include Lipid Membrane Structure and Behavior (17 papers), Organophosphorus compounds synthesis (8 papers) and Surfactants and Colloidal Systems (7 papers). H. Eibl is often cited by papers focused on Lipid Membrane Structure and Behavior (17 papers), Organophosphorus compounds synthesis (8 papers) and Surfactants and Colloidal Systems (7 papers). H. Eibl collaborates with scholars based in Germany, United States and Japan. H. Eibl's co-authors include Clemens Unger, Francisco J. Barrantes, Manuel Criado, G. Boheim, Wolfgang Hanke, E. A. M. Fleer, Edward E. Hill, William E.M. Lands, L.L.M. Van Deenen and Georg Nagel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

H. Eibl

65 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Eibl Germany	27	1.6k	418	333	272	251	66	2.4k
Sheldon M. Schuster United States	27	1.8k 1.2×	182 0.4×	179 0.5×	288 1.1×	112 0.4×	104	2.6k
Brigitte Meunier France	36	2.5k 1.6×	190 0.5×	338 1.0×	113 0.4×	300 1.2×	123	3.8k
B. De Kruyff Netherlands	18	2.8k 1.8×	336 0.8×	76 0.2×	422 1.6×	117 0.5×	20	3.5k
James K. Coward United States	37	2.9k 1.8×	1.1k 2.7×	215 0.6×	802 2.9×	172 0.7×	160	4.0k
H. Tuppy Austria	21	1.5k 0.9×	382 0.9×	72 0.2×	100 0.4×	234 0.9×	74	2.4k
Arend J. Slotboom Netherlands	33	2.8k 1.8×	202 0.5×	84 0.3×	465 1.7×	83 0.3×	90	3.7k
Robert L. Switzer United States	36	3.4k 2.2×	126 0.3×	80 0.2×	268 1.0×	359 1.4×	126	4.1k
L B Chen United States	12	1.4k 0.9×	129 0.3×	117 0.4×	64 0.2×	151 0.6×	12	2.7k
F. Niesen United Kingdom	19	2.7k 1.7×	211 0.5×	102 0.3×	97 0.4×	162 0.6×	25	3.5k
Abdellah Allali‐Hassani Canada	34	3.3k 2.1×	220 0.5×	111 0.3×	96 0.4×	318 1.3×	60	4.1k

Countries citing papers authored by H. Eibl

Since Specialization

Citations

This map shows the geographic impact of H. Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Eibl more than expected).

Fields of papers citing papers by H. Eibl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Eibl. The network helps show where H. Eibl may publish in the future.

Co-authorship network of co-authors of H. Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of H. Eibl. A scholar is included among the top collaborators of H. Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Eibl. H. Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doenecke, Detlef, et al.. (2015). Early Effects of Hexadecylphosphocholine on Gene Expression in Leukemia Cell Lines. Progress in tumor research. 34. 77–89.

Marschner, Norbert, et al.. (2015). Hexadecylphosphocholine and Octadecyl-methyl-glycero-3-phosphocholine: A Comparison of Hemolytic Activity, Serum Binding and Tissue Distribution. Progress in tumor research. 131–142. 17 indexed citations

Martelli, Alberto M., Verónica Papa, Pier Luigi Tazzari, et al.. (2010). Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. Leukemia. 24(4). 687–698. 26 indexed citations

Kugler, Wilfried, et al.. (2005). Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: Consequences for erucylphosphocholine-induced apoptosis. APOPTOSIS. 10(5). 1163–1174. 20 indexed citations

Unger, Clemens & H. Eibl. (2001). Arzneimittelentwicklung aus Phospholipiden. Oncology Research and Treatment. 24(1). 18–23. 3 indexed citations

Thaler, Adrian, et al.. (2000). Separation and quantification of alkylphosphocholines by reversed phase high performance liquid chromatography. Chemistry and Physics of Lipids. 107(1). 131–139. 3 indexed citations

Berger, Massimo, et al.. (1998). Erucylphosphocholine is the prototype of i. v. injectable alkylphosphocholines.. Drugs of today. 34. 73–81. 26 indexed citations

Kaufmann‐Kolle, Petra, et al.. (1996). Intravenous treatment of Leishmania donovani infected mice with liposomal hexadecylphosphocholine. Cellular & Molecular Biology Letters. 1(4). 3 indexed citations

Saran, Anil, Sudha Srivastava, Evans C. Coutinho, P. T. T. Wong, & H. Eibl. (1996). Conformation of hexadecylphosphocholine, an anticancer drug, by molecular dynamics and NMR methods. Journal of Molecular Structure. 382(1). 23–31. 3 indexed citations

10.

Kaufmann‐Kolle, Petra, Joachim Drevs, Martin R. Berger, et al.. (1994). Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine. Cancer Chemotherapy and Pharmacology. 34(5). 393–398. 26 indexed citations

11.

Eibl, H., et al.. (1992). Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrobial Agents and Chemotherapy. 36(8). 1630–1634. 164 indexed citations

12.

Vehmeyer, K., Peter Scheurich, H. Eibl, & Clemens Unger. (1991). Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2. Cellular Immunology. 137(1). 232–238. 26 indexed citations

13.

Eibl, H. & Clemens Unger. (1990). Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treatment Reviews. 17(2-3). 233–242. 110 indexed citations

14.

Fleer, E. A. M., et al.. (1990). Cytotoxic Activity of Lysophosphatidylcholine Analogues on Human Lymphoma Raji Cells. Oncology Research and Treatment. 13(4). 295–300. 30 indexed citations

15.

Unger, Clemens, E. A. M. Fleer, P. Hilgard, et al.. (1989). Hexadecylphosphocholine, a New Ether Lipid Analogue Studies on the Antineoplastic Activity in Vitro and in Vivo. Acta Oncologica. 28(2). 213–217. 90 indexed citations

16.

Schuff‐Werner, P., Ulrike Müller, Clemens Unger, Georg Nagel, & H. Eibl. (1988). 1-O-methyl-rac-glycerol: A new agent for the cryopreservation of mononuclear cells. Cryobiology. 25(6). 487–494. 6 indexed citations

17.

Eibl, H., et al.. (1988). Substrate specificity of Staphylococcus aureus (TEN5) lipases with isomeric oleoyl-sn-glycerol ethers as substrates. Chemistry and Physics of Lipids. 47(2). 117–122. 6 indexed citations

18.

Berger, Martin R., et al.. (1987). New cytostatics with experimentally different toxic profiles. Cancer Treatment Reviews. 14(3-4). 307–317. 22 indexed citations

19.

Unger, Clemens, H. Eibl, J. Engel, Georg Nagel, & Gerhard Eisenbrand. (1987). Brain uptake and CNS levels of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea (HECNU). Investigational New Drugs. 5(4). 361–364. 1 indexed citations

20.

Knoll, Wolfgang, Hans‐Jürgen Apell, H. Eibl, & A. L. Miller. (1986). Direct evidence for Ca++-induced lateral phase separation in black membranes of lipid mixtures by the analysis of gramicidin A single-channels. European Biophysics Journal. 13(3). 187–193. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact